SCHEMBL2899403

SCHEMBL2899403

O=C(OF)c1cnc2ccc(N3CCOCC3)cc2c1O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.48
GAA P10253 5/20 0.48
MEN1 O00255 5/20 0.48
KMT2A Q03164 5/20 0.48
SMN1; SMN2 Q16637 4/20 0.48
TDP1 Q9NUW8 3/20 0.48
L3MBTL1 Q9Y468 3/20 0.48
LMNA P02545 3/20 0.48
MC4R P32245 2/20 0.48
HTT P42858 2/20 0.48
PTK2B Q14289 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
CLK1 P49759 2/20 0.48
MAPK1 P28482 1/20 0.48
GSK3A P49840 1/20 0.48
GSK3B P49841 1/20 0.48
TP53 P04637 2/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
RXFP1 Q9HBX9 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2913456 0.86 GAA (0.66) MAPTGAAMEN1KMT2ASMN1; SMN2
SCHEMBL2911952 0.74 MAPT (0.68) MAPTGAAMEN1KMT2ASMN1; SMN2
SCHEMBL2910438 0.73 MEN1 (0.63) MAPTGAAMEN1KMT2ASMN1; SMN2
SCHEMBL24532111 0.73 MEN1 (0.61) MAPTGAAMEN1KMT2ASMN1; SMN2
SCHEMBL29680909 0.73 MEN1 (0.61) MAPTGAAMEN1KMT2ASMN1; SMN2
SCHEMBL24532867 0.72 MAPT (0.58) MAPTGAAMEN1KMT2ASMN1; SMN2
SCHEMBL29681249 0.72 MAPT (0.57) MAPTGAAMEN1KMT2ASMN1; SMN2
SCHEMBL24532143 0.72 MAPT (0.57) MAPTGAAMEN1KMT2ASMN1; SMN2
SCHEMBL24532295 0.71 MEN1 (0.55) MAPTMEN1KMT2ASMN1; SMN2TDP1
SCHEMBL29681119 0.71 MEN1 (0.55) MAPTMEN1KMT2ASMN1; SMN2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2166852-A1 THERAPEUTIC PYRAZOLOQUINOLINE DERIVATIVES Helicon Therapeutics, Inc. (US) 2010-03-31 EP disclosed
WO-2008154438-A1 THERAPEUTIC PYRAZOLOQUINOLINE DERIVATIVES HELICON THERAPEUTICS, INC. (US) 2008-12-18 WO disclosed